IGSF5
gene geneOn this page
Also known as JAM4
Summary
IGSF5 (immunoglobulin superfamily member 5, HGNC:5952) is a protein-coding gene on chromosome 21q22.2, encoding Immunoglobulin superfamily member 5 (Q9NSI5). Provides, together with MAGI1, an adhesion machinery at tight junctions, which may regulate the permeability of kidney glomerulus and small intestinal epithelial cells.
Predicted to enable PDZ domain binding activity. Predicted to be involved in cell-cell adhesion. Predicted to be located in apical plasma membrane. Predicted to be active in bicellular tight junction and cell surface.
Source: NCBI Gene 150084 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 61 total
- MANE Select transcript:
NM_001080444
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:5952 |
| Approved symbol | IGSF5 |
| Name | immunoglobulin superfamily member 5 |
| Location | 21q22.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | JAM4 |
| Ensembl gene | ENSG00000183067 |
| Ensembl biotype | protein_coding |
| OMIM | 610638 |
| Entrez | 150084 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 1 protein_coding, 1 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000380588, ENST00000459922, ENST00000479378
RefSeq mRNA: 1 — MANE Select: NM_001080444
NM_001080444
CCDS: CCDS33562
Canonical transcript exons
ENST00000380588 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001290607 | 39792008 | 39792099 |
| ENSE00001328914 | 39801262 | 39802081 |
| ENSE00001485574 | 39746216 | 39746298 |
| ENSE00001769493 | 39745183 | 39745526 |
| ENSE00003495748 | 39779090 | 39779305 |
| ENSE00003527190 | 39788167 | 39788188 |
| ENSE00003604826 | 39765535 | 39765852 |
| ENSE00003647311 | 39770916 | 39771215 |
| ENSE00003687559 | 39793534 | 39793613 |
Expression profiles
Bgee: expression breadth ubiquitous, 140 present calls, max score 85.53.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0050 / max 5.3751, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 189186 | 0.0050 | 3 |
Top tissues by expression
240 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.53 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 84.13 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.85 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 81.72 | silver quality |
| myocardium | UBERON:0002349 | 81.17 | silver quality |
| placenta | UBERON:0001987 | 79.91 | gold quality |
| right atrium auricular region | UBERON:0006631 | 77.40 | gold quality |
| cardiac atrium | UBERON:0002081 | 77.07 | gold quality |
| heart left ventricle | UBERON:0002084 | 76.62 | gold quality |
| cardiac ventricle | UBERON:0002082 | 76.15 | gold quality |
| heart right ventricle | UBERON:0002080 | 73.87 | gold quality |
| heart | UBERON:0000948 | 73.25 | gold quality |
| apex of heart | UBERON:0002098 | 72.18 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 70.99 | gold quality |
| pancreatic ductal cell | CL:0002079 | 69.30 | silver quality |
| right adrenal gland | UBERON:0001233 | 68.11 | gold quality |
| tibialis anterior | UBERON:0001385 | 66.91 | silver quality |
| body of pancreas | UBERON:0001150 | 66.30 | gold quality |
| left adrenal gland | UBERON:0001234 | 66.08 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 64.53 | gold quality |
| caudate nucleus | UBERON:0001873 | 64.23 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 64.22 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 64.20 | gold quality |
| adrenal cortex | UBERON:0001235 | 63.86 | gold quality |
| pancreas | UBERON:0001264 | 63.50 | gold quality |
| nucleus accumbens | UBERON:0001882 | 63.45 | gold quality |
| adrenal gland | UBERON:0002369 | 63.09 | gold quality |
| putamen | UBERON:0001874 | 62.99 | gold quality |
| ventricular zone | UBERON:0003053 | 62.22 | gold quality |
| hypothalamus | UBERON:0001898 | 61.58 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.92 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
58 targeting IGSF5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-4760-3P | 99.93 | 70.50 | 2385 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-380-3P | 99.89 | 70.18 | 1978 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-4420 | 99.82 | 70.08 | 1624 |
| HSA-MIR-181B-2-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-181B-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-2052 | 99.79 | 69.37 | 2031 |
| HSA-MIR-3659 | 99.70 | 67.97 | 694 |
| HSA-MIR-7161-5P | 99.68 | 68.92 | 1592 |
| HSA-MIR-6516-3P | 99.65 | 68.57 | 1238 |
| HSA-MIR-548U | 99.65 | 67.78 | 1463 |
| HSA-MIR-488-3P | 99.61 | 68.79 | 1731 |
| HSA-MIR-3942-3P | 99.57 | 69.03 | 2854 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-486-3P | 99.51 | 66.82 | 1901 |
| HSA-MIR-5007-3P | 99.51 | 68.14 | 1242 |
| HSA-MIR-2392 | 99.43 | 67.50 | 708 |
Cross-species orthologs
14 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ntm | ENSDARG00000018065 |
| drosophila_melanogaster | Ama | FBGN0000071 |
| drosophila_melanogaster | Lac | FBGN0010238 |
| drosophila_melanogaster | klg | FBGN0017590 |
| drosophila_melanogaster | fipi | FBGN0031627 |
| drosophila_melanogaster | DIP-eta | FBGN0031725 |
| drosophila_melanogaster | DIP-iota | FBGN0031837 |
| drosophila_melanogaster | CG13506 | FBGN0034723 |
| drosophila_melanogaster | DIP-zeta | FBGN0051708 |
| drosophila_melanogaster | DIP-kappa | FBGN0051814 |
| drosophila_melanogaster | CG33543 | FBGN0053543 |
| drosophila_melanogaster | DIP-beta | FBGN0259245 |
| drosophila_melanogaster | DIP-epsilon | FBGN0259714 |
| caenorhabditis_elegans | rig-5 | WBGENE00004372 |
Paralogs (5): IGLON5 (ENSG00000142549), NEGR1 (ENSG00000172260), NTM (ENSG00000182667), OPCML (ENSG00000183715), LSAMP (ENSG00000185565)
Protein
Protein identifiers
Immunoglobulin superfamily member 5 — Q9NSI5 (reviewed: Q9NSI5)
Alternative names: Junctional adhesion molecule 4
All UniProt accessions (1): Q9NSI5
UniProt curated annotations — full annotation on UniProt →
Function. Provides, together with MAGI1, an adhesion machinery at tight junctions, which may regulate the permeability of kidney glomerulus and small intestinal epithelial cells. Mediates calcium-independent homophilic cell adhesion. In testis, it may function as a cell adhesion molecule rather than a tight-junction protein. It may participate in the adhesion between spermatogonia-spermatogonia, spermatogonia-Sertoli cells, and Sertoli cells-Sertoli cells.
Subunit / interactions. Interacts with MAGI1 at tight junctions, forms a tripartite complex with NPHS1. Interacts with LNX1 isoform 2 via its PDZ 2 domain, it may also interact with other isoforms containing this domain.
Subcellular location. Apical cell membrane. Cell junction. Tight junction.
Miscellaneous. A protein of the expected size has been detected by antibody binding and Western blot in at least one of the analyzed tissues or cells.
Similarity. Belongs to the immunoglobulin superfamily.
RefSeq proteins (1): NP_001073913* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003599 | Ig_sub | Domain |
| IPR007110 | Ig-like_dom | Domain |
| IPR013098 | Ig_I-set | Domain |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR036179 | Ig-like_dom_sf | Homologous_superfamily |
Pfam: PF07679
UniProt features (19 total): glycosylation site 4, sequence variant 4, topological domain 2, disulfide bond 2, domain 2, compositionally biased region 2, chain 1, transmembrane region 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NSI5-F1 | 66.04 | 0.32 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (2): 60–123, 163–215
Glycosylation sites (4): 103, 210, 231, 59
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 40 (showing top):
GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN, GOCC_CELL_SURFACE, KEGG_TIGHT_JUNCTION, GOBP_CELL_CELL_ADHESION, SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP, GOCC_APICAL_PLASMA_MEMBRANE, GOCC_CELL_CELL_JUNCTION, chr21q22, CUI_TCF21_TARGETS_2_UP, KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION, GOCC_APICAL_PART_OF_CELL, GOCC_ANCHORING_JUNCTION, GOCC_PLASMA_MEMBRANE_REGION, WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
GO Biological Process (1): cell-cell adhesion (GO:0098609)
GO Molecular Function (0):
GO Cellular Component (6): bicellular tight junction (GO:0005923), cell surface (GO:0009986), apical plasma membrane (GO:0016324), plasma membrane (GO:0005886), membrane (GO:0016020), anchoring junction (GO:0070161)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| cell adhesion | 1 |
| apical junction complex | 1 |
| tight junction | 1 |
| apical part of cell | 1 |
| plasma membrane region | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cell junction | 1 |
Protein interactions and networks
STRING
452 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| IGSF5 | MAGI1 | Q96QZ7 | 935 |
| IGSF5 | OCLN | Q16625 | 906 |
| IGSF5 | F11R | Q9Y624 | 789 |
| IGSF5 | TJP1 | Q07157 | 756 |
| IGSF5 | JAM2 | P57087 | 698 |
| IGSF5 | JAM3 | Q9BX67 | 692 |
| IGSF5 | JAML | Q86YT9 | 671 |
| IGSF5 | MARVELD2 | Q8N4S9 | 652 |
| IGSF5 | LNX1 | Q8TBB1 | 646 |
| IGSF5 | ESAM | Q96AP7 | 604 |
| IGSF5 | CXADR | P78310 | 596 |
| IGSF5 | CLMP | Q9H6B4 | 565 |
| IGSF5 | CLDN12 | P56749 | 480 |
| IGSF5 | EDRF1 | Q3B7T1 | 474 |
| IGSF5 | TMEM236 | Q5W0B7 | 469 |
IntAct
116 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| IGSF5 | LNX2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | MAST2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | DLG3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | PDZD7 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | DLG1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | MAST1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SNX27 | IGSF5 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | HTRA1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | DLG4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | MAGI3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | DLG2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | TAMALIN | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | GORASP2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | RADIL | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| DLG1 | IGSF5 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | ARHGEF11 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | ARHGEF12 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | PICK1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | GORASP1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | MAGI2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | PDZD2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | TIAM2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | SNTA1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | SNTB1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| APBA3 | IGSF5 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | MPP2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | PDZRN4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | PTPN13 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| IGSF5 | ARHGAP21 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
BioGRID (12): IGSF5 (Proximity Label-MS), NOTCH3 (Affinity Capture-MS), NOTCH1 (Affinity Capture-MS), NOTCH2 (Affinity Capture-MS), PASK (Affinity Capture-MS), N4BP2L2 (Affinity Capture-MS), LDLR (Affinity Capture-MS), LRP4 (Affinity Capture-MS), CRELD2 (Affinity Capture-MS), IGSF5 (Two-hybrid), LNX1 (Two-hybrid), LNX2 (Two-hybrid)
ESM2 similar proteins: A0A0R4IGV4, A0A8M2B818, A0JM41, A2VD98, B0CLX4, B6ZK77, D3YX43, F1LW30, O00241, O18906, O54901, O88775, O95256, P00545, P04218, P0C673, P10522, P13369, P17948, P21995, P27931, P35916, P35917, P35969, P37301, P42071, P42703, P53767, Q08DK1, Q15762, Q58EG3, Q5DX21, Q5FWR8, Q5R412, Q5U2P2, Q5VJ70, Q6GMZ9, Q6PCB8, Q6X936, Q7TSN7
Diamond homologs: Q5VJ70, Q7TSN7, Q9NSI5
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 79 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Ras activation upon Ca2+ influx through NMDA receptor | 5 | 56.0× | 1e-06 |
| Unblocking of NMDA receptors, glutamate binding and activation | 5 | 53.3× | 1e-06 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | 5 | 53.3× | 1e-06 |
| Long-term potentiation | 5 | 46.6× | 2e-06 |
| Assembly and cell surface presentation of NMDA receptors | 9 | 44.8× | 3e-11 |
| Neurexins and neuroligins | 10 | 38.6× | 1e-11 |
| Protein-protein interactions at synapses | 6 | 31.2× | 1e-06 |
| RHOB GTPase cycle | 5 | 15.1× | 4e-04 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| establishment or maintenance of epithelial cell apical/basal polarity | 11 | 84.1× | 1e-16 |
| protein localization to synapse | 6 | 60.5× | 6e-08 |
| receptor clustering | 7 | 57.5× | 6e-09 |
| regulation of postsynaptic membrane neurotransmitter receptor levels | 7 | 45.6× | 2e-08 |
| protein-containing complex assembly | 9 | 13.5× | 2e-06 |
| cell-cell adhesion | 10 | 13.4× | 3e-07 |
| regulation of small GTPase mediated signal transduction | 5 | 9.5× | 4e-03 |
| chemical synaptic transmission | 7 | 7.1× | 1e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
61 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 45 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1357 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:39749083:G:GT | donor_gain | 1.0000 |
| 21:39770912:TTA:T | acceptor_loss | 1.0000 |
| 21:39770914:A:AG | acceptor_gain | 1.0000 |
| 21:39770914:AG:A | acceptor_loss | 1.0000 |
| 21:39770915:G:GG | acceptor_gain | 1.0000 |
| 21:39770915:GTT:G | acceptor_gain | 1.0000 |
| 21:39770915:GTTAT:G | acceptor_gain | 1.0000 |
| 21:39771213:AAGG:A | donor_loss | 1.0000 |
| 21:39771216:G:GA | donor_loss | 1.0000 |
| 21:39771216:G:GG | donor_gain | 1.0000 |
| 21:39792096:ACAGG:A | donor_loss | 1.0000 |
| 21:39792098:AGG:A | donor_loss | 1.0000 |
| 21:39792099:GGTG:G | donor_loss | 1.0000 |
| 21:39792100:G:GA | donor_loss | 1.0000 |
| 21:39792101:T:A | donor_loss | 1.0000 |
| 21:39793528:TTGCA:T | acceptor_loss | 1.0000 |
| 21:39793529:TGCA:T | acceptor_loss | 1.0000 |
| 21:39793530:GCA:G | acceptor_loss | 1.0000 |
| 21:39793531:CAG:C | acceptor_loss | 1.0000 |
| 21:39793532:A:AG | acceptor_gain | 1.0000 |
| 21:39793532:A:C | acceptor_loss | 1.0000 |
| 21:39793533:G:GC | acceptor_gain | 1.0000 |
| 21:39793533:G:GT | acceptor_loss | 1.0000 |
| 21:39793533:GA:G | acceptor_gain | 1.0000 |
| 21:39793533:GAC:G | acceptor_gain | 1.0000 |
| 21:39793533:GACA:G | acceptor_gain | 1.0000 |
| 21:39770915:GT:G | acceptor_gain | 0.9900 |
| 21:39770915:GTTA:G | acceptor_gain | 0.9900 |
| 21:39771214:AG:A | donor_gain | 0.9900 |
| 21:39771215:GG:G | donor_gain | 0.9900 |
AlphaMissense
2669 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 21:39765647:G:C | W71C | 0.996 |
| 21:39765647:G:T | W71C | 0.996 |
| 21:39765606:T:C | F58L | 0.993 |
| 21:39765608:C:A | F58L | 0.993 |
| 21:39765608:C:G | F58L | 0.993 |
| 21:39765632:G:C | W66C | 0.993 |
| 21:39765632:G:T | W66C | 0.993 |
| 21:39765645:T:A | W71R | 0.991 |
| 21:39765645:T:C | W71R | 0.991 |
| 21:39765607:T:C | F58S | 0.990 |
| 21:39765607:T:G | F58C | 0.987 |
| 21:39765630:T:A | W66R | 0.986 |
| 21:39765630:T:C | W66R | 0.986 |
| 21:39771025:G:C | W176C | 0.986 |
| 21:39771025:G:T | W176C | 0.986 |
| 21:39765711:T:C | F93L | 0.985 |
| 21:39765713:C:A | F93L | 0.985 |
| 21:39765713:C:G | F93L | 0.985 |
| 21:39765801:T:A | C123S | 0.983 |
| 21:39765802:G:C | C123S | 0.983 |
| 21:39765672:A:C | S80R | 0.982 |
| 21:39765674:C:A | S80R | 0.982 |
| 21:39765674:C:G | S80R | 0.982 |
| 21:39765757:T:C | M108T | 0.981 |
| 21:39765646:G:C | W71S | 0.974 |
| 21:39765614:C:G | C60W | 0.972 |
| 21:39771023:T:A | W176R | 0.972 |
| 21:39771023:T:C | W176R | 0.972 |
| 21:39765612:T:A | C60S | 0.971 |
| 21:39765613:G:C | C60S | 0.971 |
dbSNP variants (sampled 300 via entrez): RS1000015283 (21:39751339 A>G), RS1000101824 (21:39730777 G>C), RS1000102596 (21:39756115 AAACAAACG>A), RS1000110382 (21:39764409 C>T), RS1000125922 (21:39772121 C>T), RS1000133289 (21:39716831 C>A,T), RS1000154485 (21:39730522 C>T), RS1000157123 (21:39772436 A>C), RS1000184017 (21:39776037 A>G), RS1000224972 (21:39737767 T>C), RS1000243901 (21:39770291 C>T), RS1000262570 (21:39736569 A>C,G), RS1000313125 (21:39769884 T>C), RS1000343528 (21:39781610 C>A,T), RS1000349363 (21:39745213 A>G)
Disease associations
OMIM: gene MIM:610638 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000854_1 | Suicide risk | 6.000000e-06 |
| GCST000973_3 | Hypertension | 9.000000e-06 |
| GCST002307_7 | Systolic blood pressure (alcohol consumption interaction) | 7.000000e-07 |
| GCST002307_8 | Systolic blood pressure (alcohol consumption interaction) | 8.000000e-07 |
| GCST008513_37 | Health literacy | 9.000000e-06 |
| GCST008892_18 | Working memory | 3.000000e-06 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004321 | attempted suicide |
| EFO:0004329 | alcohol drinking |
| EFO:0006335 | systolic blood pressure |
| EFO:0010104 | health literacy measurement |
| EFO:0004335 | short-term memory |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression, increases expression | 2 |
| p-Chloromercuribenzoic Acid | affects cotreatment, decreases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | decreases expression, affects cotreatment | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Aerosols | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Estradiol | decreases expression, increases reaction | 1 |
| beta-Naphthoflavone | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): mental disorder